Illumina, Pacific Biosciences of California End Plans to Combine
January 02 2020 - 3:45PM
Dow Jones News
By Allison Prang
Illumina Inc. (ILMN) no longer will buy Pacific Biosciences of
California Inc. (PACB), the companies said Thursday.
The companies said they wouldn't do a deal "considering the
lengthy regulatory approval process the transaction has already
been subject to and continued uncertainty of the ultimate
outcome."
The deal had been announced in November 2018.
Write to Allison Prang at allison.prang@wsj.com
(END) Dow Jones Newswires
January 02, 2020 16:30 ET (21:30 GMT)
Copyright (c) 2020 Dow Jones & Company, Inc.
Pacific Biosciences of C... (NASDAQ:PACB)
Historical Stock Chart
From Apr 2024 to May 2024
Pacific Biosciences of C... (NASDAQ:PACB)
Historical Stock Chart
From May 2023 to May 2024